Spyre Therapeutics, Inc.

WELLS FARGO & COMPANY/MN SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/15/2023

8,746

Value ($000)

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/15/2023	4	0.0%	8,746	6/30/2023
2023 Q1	5/12/2023	2	0.0%	8,224	3/31/2023
2022 Q4	2/13/2023	1	0.0%	2,543	12/31/2022
2022 Q3	11/14/2022	1	0.0%	2,530	9/30/2022
2022 Q2	8/12/2022	1	0.0%	2,443	6/30/2022
2022 Q1	5/16/2022	16	0.0%	7,025	3/31/2022
2021 Q4	2/14/2022	101	0.0%	21,332	12/31/2021
2021 Q3	11/15/2021	18	0.0%	2,212	9/30/2021
2021 Q2	8/16/2021	16	0.0%	2,212	6/30/2021
2021 Q1	5/13/2021	94	0.0%	11,831	3/31/2021
2020 Q4	2/9/2021	300	0.0%	38,057	12/31/2020
2020 Q3	11/5/2020	232	0.0%	32,613	9/30/2020
2020 Q2	8/13/2020	313	0.0%	33,869	6/30/2020
2020 Q1	5/14/2020	319	0.0%	68,501	3/31/2020
2019 Q4	2/14/2020	425	0.0%	55,720	12/31/2019